Study of fertility in women with BRCA mutations
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study looks at fertility in women who carry a BRCA1 or BRCA2 gene mutation. It aims to understand how these mutations might affect a woman's ability to have children by comparing them to family members without the mutation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who has a harmful change (mutation) in the BRCA1 or BRCA2 gene.
- You are 18 years old or older.
- You do not have a mutation in any other cancer-risk gene besides BRCA.
- You are able to understand and agree to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows women who carry BRCA1 or BRCA2 gene variants (or a gene variant of unclear meaning) to learn about their risks over time. It may help improve how genetic information is used to guide future care.
This study looks at fertility, cancer outcomes, and children's health in women diagnosed with breast cancer at age 40 or younger. It aims to help you understand how breast cancer and its treatment may affect your ability to have children and your long-term health.
This study looks at how young women can preserve their ability to have children while they are getting cancer treatment. It may help by offering a structured approach to fertility planning during treatment.
This is an observational study that looks at how different cancer prevention approaches affect women with harmful (deleterious) BRCA1 or BRCA2 mutations. It may help improve future prevention and follow-up plans for women at higher inherited risk.
This study examines how different molecular subtypes (patterns of genes and proteins) of breast cancer behave in people with BRCA1 or BRCA2 mutations. By studying tumor samples and medical records, researchers hope to better predict which treatments will work best and predict long-term outcomes for BRCA-positive breast cancer patients.
This study creates a platform for women who carry a BRCA1 or BRCA2 gene mutation to be followed over time. It aims to better understand and manage cancer risks associated with these mutations.
Hear when a new Fertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.